FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230281283> ?p ?o ?g. }

• W4230281283 endingPage "474" @default.
• W4230281283 startingPage "461" @default.
• W4230281283 abstract "PC12 cells have previously been shown to cease cell division during nerve growth-factor (NGF)-induced differentiation by affecting specific cell cycle proteins. Staurosporine, a protein kinase inhibitor, also causes PC12 cell differentiation, independently of neurotrophins or plasma membrane receptors. We have investigated the relationship of the tumor suppressor protein, p53, and other cell cycle proteins to the antiproliferative effects of NGF and staurosporine in PC12 cells. NGF treatment of PC12 cells stimulated an increase of p53 protein in the nucleus and, more slowly, an increase in total cellular p53 protein. Levels of the cyclin-kinase inhibitor p21/WAF1, cyclin D1, and cyclin G, all downstream transcriptional targets of p53, increased after short times of NGF treatment. Cessation of replication and differentiation occurred more rapidly in defined medium (2 days) than in serum medium (6 days), in correspondence with the more rapid changes in both p53 and p21/WAF1 levels in defined medium (1 hour) than in serum (1 day). Levels of p34cdc2 and p33cdk2 kinase dropped after 6 to 10 days treatment with NGF in serum, close to the time of terminal differentiation. Staurosporine, on the other hand, inhibited DNA replication of PC12 cells in a time- and dose-dependent fashion by affecting cyclin-dependent kinases. Staurosporine had no effect on the protein levels of p53, p21/WAF1, or cyclin G. The kinase activity of both p34cdc2 and p33cdk2 were inhibited in vitro with IC50 values of 20 nM and 75 nM, respectively. In vivo p34cdc2 kinase activity was inhibited within 1 day, before the decrease in the levels of p34cdc2 protein at days 2 to 3. In contrast, in vivo p33cdk2 kinase activity only decreased in concert with protein levels. Although both NGF and staurosporine inhibit DNA replication concomitant with induction of differentiation by affecting the activity of p34cdc2 and p33cdk2, the mechanism of the two agents is quite different. NGF achieves inhibition of activity of these cyclin-dependent kinases by signalling through the TrkA receptor to the tumor supressor protein p53 and then to p21/WAF1. In contrast, staurosporine directly inhibits the activity of p34cdc2 and p33cdk2 by binding to them and also indirectly by alteration of their phosphorylation through other regulatory kinases. J. Neurosci. Res. 49:461–474, 1997. © 1997 Wiley-Liss, Inc." @default.
• W4230281283 created "2022-05-11" @default.
• W4230281283 creator A5004485787 @default.
• W4230281283 creator A5015612274 @default.
• W4230281283 date "1997-08-15" @default.
• W4230281283 modified "2023-09-25" @default.
• W4230281283 title "Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine" @default.
• W4230281283 doi "https://doi.org/10.1002/(sici)1097-4547(19970815)49:4<461::aid-jnr7>3.3.co;2-6" @default.
• W4230281283 hasPublicationYear "1997" @default.
• W4230281283 type Work @default.
• W4230281283 citedByCount "0" @default.
• W4230281283 crossrefType "journal-article" @default.
• W4230281283 hasAuthorship W4230281283A5004485787 @default.
• W4230281283 hasAuthorship W4230281283A5015612274 @default.
• W4230281283 hasConcept C124320809 @default.
• W4230281283 hasConcept C1491633281 @default.
• W4230281283 hasConcept C153911025 @default.
• W4230281283 hasConcept C16438837 @default.
• W4230281283 hasConcept C170493617 @default.
• W4230281283 hasConcept C184235292 @default.
• W4230281283 hasConcept C2778423431 @default.
• W4230281283 hasConcept C2779084600 @default.
• W4230281283 hasConcept C29537977 @default.
• W4230281283 hasConcept C55493867 @default.
• W4230281283 hasConcept C62112901 @default.
• W4230281283 hasConcept C82495950 @default.
• W4230281283 hasConcept C86803240 @default.
• W4230281283 hasConcept C94561458 @default.
• W4230281283 hasConcept C95444343 @default.
• W4230281283 hasConcept C97029542 @default.
• W4230281283 hasConceptScore W4230281283C124320809 @default.
• W4230281283 hasConceptScore W4230281283C1491633281 @default.
• W4230281283 hasConceptScore W4230281283C153911025 @default.
• W4230281283 hasConceptScore W4230281283C16438837 @default.
• W4230281283 hasConceptScore W4230281283C170493617 @default.
• W4230281283 hasConceptScore W4230281283C184235292 @default.
• W4230281283 hasConceptScore W4230281283C2778423431 @default.
• W4230281283 hasConceptScore W4230281283C2779084600 @default.
• W4230281283 hasConceptScore W4230281283C29537977 @default.
• W4230281283 hasConceptScore W4230281283C55493867 @default.
• W4230281283 hasConceptScore W4230281283C62112901 @default.
• W4230281283 hasConceptScore W4230281283C82495950 @default.
• W4230281283 hasConceptScore W4230281283C86803240 @default.
• W4230281283 hasConceptScore W4230281283C94561458 @default.
• W4230281283 hasConceptScore W4230281283C95444343 @default.
• W4230281283 hasConceptScore W4230281283C97029542 @default.
• W4230281283 hasIssue "4" @default.
• W4230281283 hasLocation W42302812831 @default.
• W4230281283 hasOpenAccess W4230281283 @default.
• W4230281283 hasPrimaryLocation W42302812831 @default.
• W4230281283 hasRelatedWork W1964979363 @default.
• W4230281283 hasRelatedWork W1987680090 @default.
• W4230281283 hasRelatedWork W1988171238 @default.
• W4230281283 hasRelatedWork W1999553954 @default.
• W4230281283 hasRelatedWork W2000483549 @default.
• W4230281283 hasRelatedWork W2031511979 @default.
• W4230281283 hasRelatedWork W2045180580 @default.
• W4230281283 hasRelatedWork W2085105418 @default.
• W4230281283 hasRelatedWork W2166068722 @default.
• W4230281283 hasRelatedWork W297761204 @default.
• W4230281283 hasVolume "49" @default.
• W4230281283 isParatext "false" @default.
• W4230281283 isRetracted "false" @default.
• W4230281283 workType "article" @default.